Gamida Cell Ltd. (GMDA) SEC Filing 8-K Material Event for the period ending Wednesday, February 9, 2022

Gamida Cell Ltd.

CIK: 1600847 Ticker: GMDA

View differences made from one to another to evaluate Gamida Cell Ltd.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Gamida Cell Ltd..


Assess how Gamida Cell Ltd.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Gamida Cell Ltd.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2022 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors



Financial Statements, Disclosures and Schedules

Inside this 8-K Corporate News

Material Contracts, Statements, Certifications & more

Gamida Cell Ltd. provided additional information to their SEC Filing as exhibits

Ticker: GMDA
CIK: 1600847
Form Type: 8-K Corporate News
Accession Number: 0001213900-22-006033
Submitted to the SEC: Wed Feb 09 2022 7:30:34 AM EST
Accepted by the SEC: Wed Feb 09 2022
Period: Wednesday, February 9, 2022
Industry: Biological Products No Disgnostic Substances
  1. Financial Exhibit
  2. Other Events

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: